SAFETY AND EFFICACY OF LENABASUM IN AN OPEN-LABEL EXTENSION OF A PHASE 2 STUDY OF LENABASUM IN REFRACTORY SKIN-PREDOMINANT DERMATOMYOSITIS (DM) SUBJECTS-MedSci.cn

SAFETY AND EFFICACY OF LENABASUM IN AN OPEN-LABEL EXTENSION OF A PHASE 2 STUDY OF LENABASUM IN REFRACTORY SKIN-PREDOMINANT DERMATOMYOSITIS (DM) SUBJECTS

Werth, V; Pearson, D; Owaka, J; Feng, R; Concha, JS; Patel, B; Hejazi, E; Cornwall, C; Constantine, S; Dgetluck, N; White, B

ANNALS OF THE RHEUMATIC DISEASES, 2019; 78 (): 199

科室
- - 订阅+
  - 更多科室
工具
服务